Acquisition Completed

ELANCO finalised the acquisition of Novartis Animal Health last month. The acquisition, announced in April, followed Elanco’s purchase of Lohmann Animal Health earlier in 2014.

The purchase add nearly 300 brands to the company’s portfolio, encompassing therapeutics, vaccines, parasiticides, antimicrobials, surgical, enzymes, food safety and more.

Gaynor Hillier, general manager UK and Ireland, says the enlarged company “will be investing significantly in the development if new solutions to meet our customers’ greatest unmet needs” and will “continually seek innovative ways can support our customers’ business”.